If you’re weighing testosterone gel vs injections for long-term replacement therapy, you’re already asking the right question. Most men start TRT focused on how fast they’ll feel better. The smarter question, especially if you plan to stay on therapy for years, is which delivery method is least likely to cause trouble down the road.
The honest answer is that both are FDA-approved options for diagnosed hypogonadism, and both have decades of clinical use behind them. They just fail in different ways. Gels tend to cause skin issues and household exposure risks. Injections tend to cause hormonal roller-coasters and red blood cell elevations.
So which one wins on long-term safety? It depends on your skin, your living situation, your hematocrit, and how stable you want your hormone levels to feel day to day.
How testosterone gel vs injections actually deliver the hormone
Topical gels (brand names like AndroGel, Testim, Fortesta) deliver testosterone through the skin once daily. Absorption is gradual, which produces relatively steady serum levels that mimic the body’s natural rhythm reasonably well.
Injections (typically testosterone cypionate or enanthate) are usually given intramuscularly or subcutaneously every 7 to 14 days. They produce a peak shortly after the shot, then a slow decline until the next dose. Some men feel that swing. Others don’t notice it at all.
That difference in pharmacokinetics drives most of the long-term safety differences between the two.
Long-term side effect profile
Both formulations share the core TRT risk list: acne, sleep apnea worsening, fertility suppression, possible prostate effects, and elevated hematocrit. But the rates aren’t equal.
Gels are more associated with:
- Skin irritation at the application site (roughly 5 to 15 percent of users)
- Secondary transfer to partners or children through skin contact
- Inconsistent absorption, especially in men with very dry or very oily skin
- Lower peak levels, which some men find subtherapeutic
Injections are more associated with:
- Elevated hematocrit and polycythemia (one of the biggest long-term concerns)
- Mood swings tied to the peak-trough cycle
- Estradiol spikes after the injection peak
- Injection-site soreness, and rarely, sterile abscesses
The Endocrine Society’s clinical practice guidelines flag erythrocytosis as one of the more consistent long-term risks with injectable testosterone, particularly at higher doses or longer intervals. That’s the issue most TRT clinics monitor with quarterly bloodwork.
The transference problem with gels
This is the one gel-specific risk the FDA takes seriously. Testosterone gel can transfer to anyone you touch with the application site, including children and pregnant partners. The FDA added a boxed warning years ago after cases of virilization in children exposed to topical testosterone were reported.
In practice, the workaround is straightforward: apply after morning shower, let it dry fully, cover with a shirt, and wash hands. But if you have small kids climbing on you or a partner trying to conceive, this matters.
Cardiovascular safety: what the recent data says
For years, men starting TRT got conflicting signals about heart risk. The 2023 TRAVERSE trial, published in NEJM, helped settle some of it. In roughly 5,200 middle-aged and older men with hypogonadism and cardiovascular risk factors, transdermal testosterone was not associated with a higher rate of major adverse cardiovascular events compared to placebo over an average follow-up of 22 months.
What TRAVERSE did find: slightly more atrial fibrillation, pulmonary embolism, and acute kidney injury in the testosterone group. Those are not trivial signals, but they apply broadly to TRT, not specifically to one formulation.
We don’t have an equivalent gold-standard trial directly comparing testosterone gel vs injections head-to-head on cardiovascular endpoints. What we do have is registry data suggesting injectable testosterone produces higher hematocrit elevations, which is a plausible mechanism for clot-related events. If you have a personal or family history of clots, that nudges the conversation toward gels.
Convenience, cost, and adherence
A safer drug you stop taking isn’t safer. Adherence matters.
Gels require daily application, which some men find tedious after the novelty wears off. Injections, done weekly or every two weeks, are easier to remember but require comfort with self-injection. If needles are a hard no for you, that’s a real factor.
On cost, generic testosterone cypionate injections are typically much cheaper than branded gels. A vial can last weeks and runs a fraction of what a monthly gel supply costs without insurance. You can compare current pricing on testosterone formulations at edrugstore.com to see what your out-of-pocket would look like.
For men curious about other delivery options, our breakdowns of testosterone pellets versus injections and oral TRT formulations cover the trade-offs in detail.
Who tends to do better on which
These aren’t rules, just patterns clinicians see often:
- Men with young kids at home, sensitive skin, or partners trying to conceive often do better on injections
- Men with a history of polycythemia, high baseline hematocrit, or clotting disorders often do better on gels
- Men who travel constantly and hate carrying needles often prefer gels
- Men chasing very stable mood and energy levels often prefer gels or twice-weekly low-dose injections
The Mayo Clinic’s overview of testosterone therapy makes a useful point: long-term TRT is a monitoring relationship, not a one-time prescription. Whichever formulation you start, expect bloodwork every 3 to 6 months for the first year, then at least annually after that.
If TRT is part of a broader workup that includes erectile concerns, our comparison of tadalafil daily versus on-demand dosing may also be worth a read, since the two issues often overlap.
The bottom line on testosterone gel vs injections
Neither option is universally "safer." For most healthy men with no clotting history and a stable home environment, testosterone gel vs injections comes down to lifestyle fit more than safety. For men with elevated hematocrit risk, gels have a small edge. For men in households with young children or pregnant partners, injections sidestep the transference issue entirely.
Whichever you lean toward, the long-term safety of any TRT comes down to monitoring: regular labs, honest symptom tracking, and a prescriber who adjusts the dose rather than setting it and forgetting it. Ask your doctor about a baseline CBC, PSA, and estradiol before starting, and discuss which formulation fits both your body and your daily life.
This article is for informational purposes only and is not medical advice. Always consult a licensed pharmacist or physician before starting, stopping, or changing any medication.
References
- FDA Testosterone Drug Safety Information, Regulatory status and safety communications for testosterone products.
- FDA Boxed Warning on Topical Testosterone Transference, Pediatric and partner exposure risks specific to gels.
- Endocrine Society Clinical Practice Guidelines, Long-term monitoring recommendations for men on TRT.
- Mayo Clinic: Testosterone Therapy Overview, Plain-language summary of TRT benefits, risks, and monitoring.
Dr Steven Schlosser
Dr. Schlosser graduated from Lafayette College Phi Beta Kappa and attended Georgetown Medical School. He had 4 years of medical residency training at Tufts University in Boston in both Gynecology and Internal Medicine. He has had a spotless medical career for the past 40+ years and is Board Certified. Learn More